Product image of Leflunomide Sandoz (Leflunomide) supplied by GNH India

Leflunomide Sandoz

Active Ingredient:
Leflunomide
Origin:
EU

Leflunomide Sandoz (Leflunomide)

Leflunomide, the active ingredient in Leflunomide Sandoz, is an immunomodulatory agent presented as an oral tablet for systemic use. It is used to treat rheumatoid arthritis in adult patients by modifying disease progression and reducing inflammatory symptoms. It belongs to the disease-modifying antirheumatic drug (DMARD) class and is approved in the European Union for long-term management of rheumatoid arthritis.

GNH India supplies Leflunomide Sandoz as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The company adheres to stringent quality standards and provides reliable supply chains to meet global demand.

Manufacturer / TM Owner

Sandoz Ltd

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Leflunomide is a disease-modifying antirheumatic drug (DMARD) used primarily in rheumatology.
  • Rheumatoid arthritis (moderate to severe): reduces joint inflammation and slows structural damage.
  • Early rheumatoid arthritis: helps achieve disease control when combined with other DMARDs.
  • Active rheumatoid arthritis: improves functional ability and reduces pain.

How It Works

  • Leflunomide inhibits the mitochondrial enzyme dihydroorotate dehydrogenase, which is essential for de novo pyrimidine synthesis. By limiting pyrimidine availability, the drug suppresses proliferation of activated lymphocytes, thereby reducing the immune-mediated inflammation characteristic of rheumatoid arthritis.

Side Effects

Leflunomide may cause a range of adverse reactions. Patients should be aware of both common and serious possibilities.

Common Side Effects

  • Diarrhea: loose stools or increased frequency.
  • Nausea: feeling of sickness or urge to vomit.
  • Headache: mild to moderate cranial pain.
  • Hypertension: elevated blood pressure readings.
  • Alopecia: thinning or loss of hair.
  • Rash: skin irritation or redness.

Serious or Rare Side Effects

  • Hepatotoxicity: significant liver enzyme elevations or liver injury.
  • Severe infections: opportunistic or bacterial infections requiring medical attention.
  • Pulmonary toxicity: interstitial lung disease or pneumonitis.
  • Stevens‑Johnson syndrome: severe skin reaction with blistering.
  • Bone marrow suppression: decreased blood cell counts.
  • Severe hypertension: markedly high blood pressure that may lead to complications.

Precautions & Warnings

  • Before initiating therapy, clinicians should evaluate several safety parameters and monitor patients regularly.
  • Monitor liver function: obtain baseline and periodic liver enzyme tests.
  • Check blood pressure: measure regularly and manage elevations.
  • Assess for infections: avoid starting therapy in patients with active infections.
  • Avoid use in severe hepatic impairment: contraindicated in significant liver disease.
  • Pregnancy and breastfeeding: discuss potential risks with the prescriber.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Leflunomide can interact with several medicines, requiring careful management.

Major Interactions (Avoid)

  • Methotrexate: increased risk of hepatotoxicity.
  • Warfarin: potentiated anticoagulant effect, raising bleeding risk.
  • Live vaccines: heightened risk of severe infection.

Moderate Interactions (Monitor Closely)

  • Statins: possible myopathy when combined.
  • Azathioprine: additive bone marrow suppression.

Frequently Asked Questions

Leflunomide Sandoz contains the active ingredient leflunomide, an immunomodulatory disease-modifying antirheumatic drug (DMARD). It is prescribed to manage rheumatoid arthritis in adult patients, helping to reduce joint inflammation, pain, and long‑term structural damage.

Leflunomide inhibits dihydroorotate dehydrogenase, an enzyme required for pyrimidine synthesis. This limits the proliferation of activated lymphocytes, thereby dampening the immune response that drives inflammation in rheumatoid arthritis.

The appropriate dose of Leflunomide Sandoz is determined by the prescribing physician based on the individual’s clinical condition, response to therapy, and safety considerations. Patients should follow the specific dosing instructions provided by their healthcare professional.

Leflunomide is generally not recommended for use during pregnancy or while breastfeeding because it may pose risks to the developing fetus or infant. Women of child‑bearing potential should discuss contraception and potential alternatives with their prescriber.

To request Leflunomide Sandoz, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Leflunomide belongs to the DMARD class and differs from biologic agents such as TNF inhibitors. It is taken orally and works by inhibiting lymphocyte proliferation, whereas biologics target specific cytokines. The choice between leflunomide and other therapies depends on disease severity, patient preference, comorbidities and physician assessment.

Leflunomide Sandoz tablets should be stored at ambient temperature, below 25 °C, in the original packaging. Protect the product from moisture, direct sunlight, and excessive heat to maintain its stability and potency.

Leflunomide Sandoz is administered orally, typically as a tablet taken with or without food. The exact schedule and any loading dose are determined by the prescribing clinician based on the patient’s therapeutic needs.

Serious risks include hepatotoxicity (liver injury), severe infections, pulmonary toxicity, and rare skin reactions such as Stevens‑Johnson syndrome. Patients should be monitored regularly for liver function, signs of infection, and respiratory symptoms, and should report any concerning changes promptly.

Leflunomide Sandoz is contraindicated in patients with severe hepatic impairment, active serious infections, or known hypersensitivity to leflunomide. Caution is also advised for individuals with pre‑existing hypertension, pregnancy, or breastfeeding status.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Leflunomide

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT